Capital Building in Washington DC

Advocacy & Policy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • FDA Commissioner Talks Drug Pricing and More in Advocacy Podcast

    In the latest ASCO in Action Podcast, FDA Commissioner Dr. Scott Gottlieb joins ASCO CEO Dr. Clifford A. Hudis for an exclusive interview on FDA’s role in tackling drug pricing, combating the spike in tobacco use in teens, and improving the expanded access program.

    Listen Now
  • ASCO Joins Groups Urging Congress to Reject Proposed Changes to Medicare Part D

    ASCO, along with nearly 60 other organizations, joined the American Cancer Society Cancer Action Network in an advertising campaign due to concerns that the proposed changes to Part D would remove important protections for patients with serious illnesses including cancer.

    Learn More
  • As New Congress Begins, ASCO Sharpens 2019 Policy Priorities

    ASCO will continue its efforts to advance policy priorities including: federal funding for cancer research, patient access to clinical trials, oral parity legislation, and other potential barriers to care such as the high cost of cancer drug treatment, step therapy, and prior authorization policies.

    Read More

Random Quote

"ASCO is the world’s largest and arguably most influential oncology organization… a dynamic organization that not only is advancing the frontiers of research, providing outstanding educational opportunities, and defining standards of practice for clinical care, but also influencing public policy."
Anees Chagpar, MD
ASCO Member since 2003